+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Krabbe Disease Treatment Market - Global Forecast 2025-2030- Product Image
Krabbe Disease Treatment Market - Global Forecast 2025-2030- Product Image
Sale

Krabbe Disease Treatment Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5889078
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Leadership teams must navigate the rapidly evolving Krabbe Disease Treatment Market as technology reshapes therapeutic approaches and heightens stakeholder interest. Streamlined diagnostics, emerging gene therapies, and complex supply chain factors all demand informed, agile strategies to stay competitive.

Market Snapshot: Krabbe Disease Treatment Market Overview

The Krabbe Disease Treatment Market grew from USD 1.83 billion in 2024 to USD 1.95 billion in 2025. It is expected to continue growing at a CAGR of 6.60%, reaching USD 2.68 billion by 2030. This upward trajectory is fueled by innovations in gene and cell therapies, expanded newborn screening, and evolving regulatory pathways. The ongoing introduction of advanced diagnostic tools and movement toward early intervention are reconfiguring both clinical outcomes and commercial dynamics.

Scope & Segmentation

  • Therapy Types: Includes enzyme replacement therapy, gene therapy (AAV2, AAV9, lentiviral vectors—second and third generation), hematopoietic stem cell transplantation (allogeneic, autologous), and supportive therapy options.
  • Administration Routes: Covers intrathecal (intracerebroventricular, lumbar puncture) and intravenous (central venous catheter, peripheral vein) approaches.
  • Treatment Settings: Segment includes inpatient (specialty clinics, tertiary hospitals) and outpatient care (ambulatory clinics, home care settings).
  • Distribution Channels: Involves hospital pharmacy, online pharmacy, retail pharmacy, independent specialty pharmacies, and managed specialty pharmacies.
  • End Users: Focus on clinics (multispecialty, specialty), home care providers (licensed nursing agencies, patient’s home), and hospitals (children’s, general).
  • Patient Age Groups: Considers symptomatic infantile, late onset adolescent and adult, and neonatal populations (early diagnosis, presymptomatic).
  • Regional Coverage: Factors in market trends and access strategies across the Americas (with U.S. state-level detail), Europe, Middle East & Africa, and Asia-Pacific regions including key markets such as China, India, and Japan.
  • Key Industry Organizations: Analysis includes Passage Bio, Inc., Bluebird Bio, Inc., Généthon, Forge Biologics, and Polaryx Therapeutics.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Emerging gene therapies and novel vectors are quickly redefining disease management, moving the field from palliative strategies toward curative potential.
  • Early intervention is increasingly possible thanks to improved newborn screening and advanced diagnostics, demanding closer alignment between payers, providers, and manufacturers.
  • Collaborations among academic, regulatory, and advocacy groups support streamlined clinical translation, while also ensuring standards in outcome measurement and data sharing.
  • Investment in innovative supply chain resilience models is essential, especially under shifting global trade and tariff environments.
  • Segmental differences—by therapy type, administration route, and patient demographics—shape market access and commercialization strategies across regions.
  • Integrated health economics expertise enables better disease modeling, supporting both favorable reimbursement and patient access.

Tariff Impact on the Krabbe Disease Therapeutic Ecosystem

Recent tariff adjustments in the United States have introduced higher costs for key manufacturing inputs, affecting the pricing structures of gene therapy vectors and related materials. These pressures are prompting biopharmaceutical companies to evaluate new procurement strategies, consider onshore retooling, and seek partnerships for manufacturing outside of affected jurisdictions. Lead time variability and rising R&D costs emphasize the need for robust, flexible supply chains in order to maintain commercialization timelines and patient access.

Methodology & Data Sources

This report integrates primary research—drawing on interviews with key opinion leaders and expert advisory panels—and systematic secondary research that includes reviews of peer-reviewed publications and regulatory filings. Proprietary databases support data accuracy, while all findings undergo triangulation and multi-stage quality assurance for reliability.

Why This Report Matters

  • Enables C-suite leaders to confidently assess investment opportunities by presenting granular segmentation and emerging therapy trends relevant to the Krabbe Disease Treatment Market.
  • Supports actionable planning for market entry, pricing, and risk mitigation by mapping supply chain dynamics and tariff influences.
  • Delivers competitive intelligence on leading companies, new technologies, and regional strategies essential for future-proof decision-making.

Conclusion

The Krabbe Disease Treatment Market is experiencing rapid transformation through scientific advancement and global collaboration. Senior decision-makers can drive positive patient outcomes and commercial success by leveraging detailed insights and strategic recommendations presented in this report.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emerging gene editing and AAV vector approaches for targeted GALC enzyme restoration in Krabbe disease patients
5.2. Innovative small molecule chaperones designed to enhance GALC enzyme stability and function in patients
5.3. Advancements in newborn screening technologies for early detection of Krabbe disease and improved outcomes
5.4. Growing collaborations between academic institutions and biotech firms to accelerate Krabbe disease therapeutic discovery and trials
5.5. Increased patient advocacy group involvement driving funding and awareness for Krabbe disease research and treatment access
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Krabbe Disease Treatment Market, by Therapy Type
8.1. Introduction
8.2. Enzyme Replacement Therapy
8.3. Gene Therapy
8.3.1. AAV Vector
8.3.1.1. AAV2
8.3.1.2. AAV9
8.3.2. Lentiviral Vector
8.3.2.1. Second Generation
8.3.2.2. Third Generation
8.4. Hematopoietic Stem Cell Transplantation
8.4.1. Allogeneic
8.4.2. Autologous
8.5. Supportive Therapy
9. Krabbe Disease Treatment Market, by Administration Route
9.1. Introduction
9.2. Intrathecal
9.2.1. Intracerebroventricular
9.2.2. Lumbar Puncture
9.3. Intravenous
9.3.1. Central Venous Catheter
9.3.2. Peripheral Vein
10. Krabbe Disease Treatment Market, by Treatment Setting
10.1. Introduction
10.2. Inpatient
10.2.1. Specialty Clinics
10.2.2. Tertiary Hospitals
10.3. Outpatient
10.3.1. Ambulatory Clinics
10.3.2. Home Care
11. Krabbe Disease Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
11.5. Specialty Pharmacy
11.5.1. Independent Specialty Pharmacies
11.5.2. Managed Specialty Pharmacies
12. Krabbe Disease Treatment Market, by End User
12.1. Introduction
12.2. Clinics
12.2.1. Multispecialty Clinics
12.2.2. Specialty Clinics
12.3. Home Care Providers
12.3.1. Licensed Nursing Agencies
12.3.2. Patient's Home
12.4. Hospitals
12.4.1. Children's Hospitals
12.4.2. General Hospitals
13. Krabbe Disease Treatment Market, by Patient Age Group
13.1. Introduction
13.2. Infantile
13.2.1. Symptomatic
13.3. Late Onset
13.3.1. Adolescent
13.3.2. Adult
13.4. Neonatal
13.4.1. Early Diagnosis
13.4.2. Pre Symptomatic
14. Americas Krabbe Disease Treatment Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Krabbe Disease Treatment Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Krabbe Disease Treatment Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Passage Bio, Inc.
17.3.2. Bluebird Bio, Inc.
17.3.3. Généthon
17.3.4. Forge Biologics
17.3.5. Polaryx Therapeutics
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. KRABBE DISEASE TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY THERAPY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2024 VS 2030 (%)
FIGURE 10. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA KRABBE DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA KRABBE DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC KRABBE DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC KRABBE DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. KRABBE DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. KRABBE DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. KRABBE DISEASE TREATMENT MARKET: RESEARCHAI
FIGURE 28. KRABBE DISEASE TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 29. KRABBE DISEASE TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 30. KRABBE DISEASE TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. KRABBE DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY ENZYME REPLACEMENT THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY AAV VECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY AAV VECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY AAV2, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY AAV2, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY AAV9, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY AAV9, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY AAV VECTOR, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY AAV VECTOR, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY LENTIVIRAL VECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY LENTIVIRAL VECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY SECOND GENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY SECOND GENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY THIRD GENERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY THIRD GENERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY LENTIVIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY LENTIVIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY HEMATOPOIETIC STEM CELL TRANSPLANTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY HEMATOPOIETIC STEM CELL TRANSPLANTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY ALLOGENEIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY HEMATOPOIETIC STEM CELL TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY HEMATOPOIETIC STEM CELL TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY SUPPORTIVE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY SUPPORTIVE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRATHECAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRATHECAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRACEREBROVENTRICULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRACEREBROVENTRICULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY LUMBAR PUNCTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY LUMBAR PUNCTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRATHECAL, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRATHECAL, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY CENTRAL VENOUS CATHETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY CENTRAL VENOUS CATHETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY PERIPHERAL VEIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY PERIPHERAL VEIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY INPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY INPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY TERTIARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY INPATIENT, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY INPATIENT, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY OUTPATIENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY AMBULATORY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY AMBULATORY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY SPECIALTY PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY SPECIALTY PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY INDEPENDENT SPECIALTY PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY INDEPENDENT SPECIALTY PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY MANAGED SPECIALTY PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY MANAGED SPECIALTY PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY MULTISPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY MULTISPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY HOME CARE PROVIDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY HOME CARE PROVIDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY LICENSED NURSING AGENCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY LICENSED NURSING AGENCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY PATIENT'S HOME, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY PATIENT'S HOME, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY HOME CARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY HOME CARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY CHILDREN'S HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY CHILDREN'S HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY INFANTILE, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY INFANTILE, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY SYMPTOMATIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY INFANTILE, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY INFANTILE, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY LATE ONSET, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY LATE ONSET, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY ADOLESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY ADOLESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY LATE ONSET, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY LATE ONSET, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY NEONATAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY NEONATAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY EARLY DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY EARLY DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY PRE SYMPTOMATIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY PRE SYMPTOMATIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL KRABBE DISEASE TREATMENT MARKET SIZE, BY NEONATAL, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY AAV VECTOR, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY AAV VECTOR, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY LENTIVIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY LENTIVIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY HEMATOPOIETIC STEM CELL TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY HEMATOPOIETIC STEM CELL TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRATHECAL, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRATHECAL, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY INPATIENT, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY INPATIENT, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY HOME CARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY HOME CARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY INFANTILE, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY INFANTILE, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY LATE ONSET, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY LATE ONSET, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY NEONATAL, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS KRABBE DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY AAV VECTOR, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY AAV VECTOR, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY LENTIVIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY LENTIVIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY HEMATOPOIETIC STEM CELL TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY HEMATOPOIETIC STEM CELL TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRATHECAL, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRATHECAL, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY INPATIENT, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY INPATIENT, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY HOME CARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY HOME CARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY INFANTILE, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY INFANTILE, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY LATE ONSET, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY LATE ONSET, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY NEONATAL, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES KRABBE DISEASE TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 233. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 234. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 235. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 236. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 237. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY AAV VECTOR, 2018-2024 (USD MILLION)
TABLE 238. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY AAV VECTOR, 2025-2030 (USD MILLION)
TABLE 239. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY LENTIVIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 240. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY LENTIVIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 241. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY HEMATOPOIETIC STEM CELL TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 242. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY HEMATOPOIETIC STEM CELL TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 243. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 244. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 245. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRATHECAL, 2018-2024 (USD MILLION)
TABLE 246. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRATHECAL, 2025-2030 (USD MILLION)
TABLE 247. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 248. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 249. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 250. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 251. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY INPATIENT, 2018-2024 (USD MILLION)
TABLE 252. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY INPATIENT, 2025-2030 (USD MILLION)
TABLE 253. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 254. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 255. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 258. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 259. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 262. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 263. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY HOME CARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 264. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY HOME CARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 265. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 266. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 267. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 268. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 269. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY INFANTILE, 2018-2024 (USD MILLION)
TABLE 270. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY INFANTILE, 2025-2030 (USD MILLION)
TABLE 271. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY LATE ONSET, 2018-2024 (USD MILLION)
TABLE 272. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY LATE ONSET, 2025-2030 (USD MILLION)
TABLE 273. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
TABLE 274. CANADA KRABBE DISEASE TREATMENT MARKET SIZE, BY NEONATAL, 2025-2030 (USD MILLION)
TABLE 275. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 276. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 277. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY GENE THERAPY, 2018-2024 (USD MILLION)
TABLE 278. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY GENE THERAPY, 2025-2030 (USD MILLION)
TABLE 279. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY AAV VECTOR, 2018-2024 (USD MILLION)
TABLE 280. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY AAV VECTOR, 2025-2030 (USD MILLION)
TABLE 281. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY LENTIVIRAL VECTOR, 2018-2024 (USD MILLION)
TABLE 282. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY LENTIVIRAL VECTOR, 2025-2030 (USD MILLION)
TABLE 283. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY HEMATOPOIETIC STEM CELL TRANSPLANTATION, 2018-2024 (USD MILLION)
TABLE 284. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY HEMATOPOIETIC STEM CELL TRANSPLANTATION, 2025-2030 (USD MILLION)
TABLE 285. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 286. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 287. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRATHECAL, 2018-2024 (USD MILLION)
TABLE 288. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRATHECAL, 2025-2030 (USD MILLION)
TABLE 289. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, 2018-2024 (USD MILLION)
TABLE 290. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY INTRAVENOUS, 2025-2030 (USD MILLION)
TABLE 291. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2018-2024 (USD MILLION)
TABLE 292. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY TREATMENT SETTING, 2025-2030 (USD MILLION)
TABLE 293. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY INPATIENT, 2018-2024 (USD MILLION)
TABLE 294. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY INPATIENT, 2025-2030 (USD MILLION)
TABLE 295. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY OUTPATIENT, 2018-2024 (USD MILLION)
TABLE 296. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY OUTPATIENT, 2025-2030 (USD MILLION)
TABLE 297. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY SPECIALTY PHARMACY, 2018-2024 (USD MILLION)
TABLE 300. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY SPECIALTY PHARMACY, 2025-2030 (USD MILLION)
TABLE 301. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 304. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 305. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY HOME CARE PROVIDERS, 2018-2024 (USD MILLION)
TABLE 306. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY HOME CARE PROVIDERS, 2025-2030 (USD MILLION)
TABLE 307. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 308. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 309. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 310. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 311. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY INFANTILE, 2018-2024 (USD MILLION)
TABLE 312. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY INFANTILE, 2025-2030 (USD MILLION)
TABLE 313. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY LATE ONSET, 2018-2024 (USD MILLION)
TABLE 314. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY LATE ONSET, 2025-2030 (USD MILLION)
TABLE 315. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY NEONATAL, 2018-2024 (USD MILLION)
TABLE 316. MEXICO KRABBE DISEASE TREATMENT MARKET SIZE, BY NEONATAL, 2025-2030 (USD MILLION)
TABLE 317. BRAZIL KRABBE DISEASE TREATMENT MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
TABLE 318. BRAZIL KRABBE DISEASE TREATMENT MARKET SIZE, BY THERAPY TYPE, 2025-2030 (USD MILLION)
TABLE 319. BRAZIL KRABBE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Krabbe Disease Treatment market report include:
  • Passage Bio, Inc.
  • Bluebird Bio, Inc.
  • Généthon
  • Forge Biologics
  • Polaryx Therapeutics

Table Information

Report AttributeDetails
No. of Pages196
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.95 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.68 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned6

Related Topics

Related Reports

Krabbe Disease Treatment Global Market Report 2025 - Product Image

Krabbe Disease Treatment Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Krabbe Disease Treatment - Global Strategic Business Report - Product Image

Krabbe Disease Treatment - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Krabbe Disease - Pipeline Insight, 2025 - Product Image

Krabbe Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Lysosomal Disease Treatment Market Report 2025 - Product Image

Lysosomal Disease Treatment Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Gaucher's Disease Oral Therapy Market - Global Forecast 2025-2030 - Product Image

Gaucher's Disease Oral Therapy Market - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From

About the Krabbe Disease Drug Market

Krabbe Disease is a rare, inherited disorder of the central nervous system caused by a deficiency of the enzyme galactocerebrosidase. This deficiency leads to the accumulation of toxic substances in the brain and spinal cord, resulting in progressive neurological damage. Treatment for Krabbe Disease is limited to supportive care and enzyme replacement therapy. The Krabbe Disease Drug market is a small but growing segment of the Central Nervous System Drugs market. Currently, there are only a few drugs approved for the treatment of Krabbe Disease, and most of these are enzyme replacement therapies. These drugs are typically administered intravenously and are used to replace the missing enzyme in the body. The Krabbe Disease Drug market is expected to grow in the coming years as more drugs are developed and approved for the treatment of this rare disorder. Companies such as Genzyme Corporation, Shire Pharmaceuticals, and Sanofi-Aventis are actively involved in the development of new drugs for the treatment of Krabbe Disease. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.